EUVIMEDEUVIMED entdecken
Crossref

Thoracic inflammatory myofibroblastic tumors: A decade-long retrospective study integrating clinicopathological and molecular features from a tertiary care centre

Sherrin Jacob, Aruna Nambirajan, Hrishikesh Nagbhushan Gangule, Sunil Kumar, S H Chandrashekhara, Sameer Rastogi, Adarsh Barwad, Asit Ranjan Mridha, Karan Madan, Prabhat Singh Malik, Deepali Jain

Virchows Archiv · 2026-07 · 489 (1) · 159-170

DOI: 10.1007/s00428-026-04545-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virchows Archiv, online erschienen am 02.05.2026. Verfasst von Sherrin Jacob und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Neoplasms, Muscle Tissue, Biomarkers, Tumor, Thoracic Neoplasms. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory myofibroblastic tumors (IMT) are mesenchymal neoplasms of intermediate malignant potential, characterized by recurrent gene fusions in potentially targetable receptor tyrosine kinases. Primary thoracic IMTs are rare, and their molecular landscape remains incompletely characterized. A ten-year retrospective (2014-2024) clinicopathological analysis of primary thoracic IMTs was done. Histomorphological evaluation and molecular characterization by a graded approach incorporating immunohistochemistry, fluorescence-in-situ hybridization, multiplex reverse-transcription polymerase chain reaction, and next-generation targeted panel sequencing were performed for the common implicated driver fusions. Thirty IMTs involving the lung (n=17), tracheobronchial tree (n=12), and pleura (n=1) were identified. Median age at diagnosis was 18 years (range: 2 to 51 years), including 14 paediatric and 16 adult patients. Male: female ratio was 2.2:1 and 1.3:1, in adults and children, respectively. Majority (22/30, 73.3%) showed cellular spindle-cell pattern with lymphoplasmacytic inflammation. None showed significant atypia, necrosis, or mitotic activity. Molecular characterisation achieved in 22/30 cases revealed 73.3% (16/22) ALK-IMTs, 23% (5/22) ROS1-IMTs, and a single NTRK3-IMT. No statistically significant differences were seen among molecular subgroups, although ALK-IMTs were diagnosed at a higher median age (24.5 years) as compared to ROS1-IMTs (15 years). On follow-up (median follow up period: 24 months), local recurrence was observed in 23% (3/13) patients, all harbouring ALK-IMTs, one of whom was successfully treated with ALK inhibitor therapy; no disease-related deaths were recorded. Primary thoracic IMT affects children and young adults. Majority are driven by ALK gene rearrangements, followed by ROS1 alterations, underscoring role of molecular profiling in potential therapeutic stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Muscle TissueBiomarkers, TumorThoracic NeoplasmsHumansMaleFemaleMiddle AgedAdultRetrospective StudiesAdolescentChildChild, PreschoolYoung AdultTertiary Care CentersAnaplastic Lymphoma KinaseImmunohistochemistryProtein-Tyrosine KinasesIn Situ Hybridization, FluorescenceProto-Oncogene Proteins

Stichwörter der Autor:innen

ALKMultiplex PCRNGSNTRKOutcomeROS1

Substanzen

Anaplastic Lymphoma KinaseBiomarkers, TumorALK protein, humanROS1 protein, humanProtein-Tyrosine KinasesProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Surgical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Radiodiagnosis, All India Institute of Medical Sciences, Institute Rotary Cancer Hospital, New Delhi, India.
  • Department of Medical Oncology, All India Institute of Medical Sciences, Institute Rotary Cancer Hospital, New Delhi, India.
  • Department of Pulmonary Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. deepalijain76@aiims.edu.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Jacob, S., Nambirajan, A., Gangule, H. N., Kumar, S., Chandrashekhara, S. H., Rastogi, S., Barwad, A., Mridha, A. R., Madan, K., Malik, P. S., & Jain, D. (2026). Thoracic inflammatory myofibroblastic tumors: A decade-long retrospective study integrating clinicopathological and molecular features from a tertiary care centre. Virchows Archiv, 489(1), 159-170. https://doi.org/10.1007/s00428-026-04545-8

Vancouver

Jacob S, Nambirajan A, Gangule HN, Kumar S, Chandrashekhara SH, Rastogi S, et al. Thoracic inflammatory myofibroblastic tumors: A decade-long retrospective study integrating clinicopathological and molecular features from a tertiary care centre. Virchows Archiv. 2026;489(1):159-170. doi:10.1007/s00428-026-04545-8

BibTeX
@article{Jacob2026,
  author = {Jacob, Sherrin and Nambirajan, Aruna and Gangule, Hrishikesh Nagbhushan and Kumar, Sunil and Chandrashekhara, S H and Rastogi, Sameer and Barwad, Adarsh and Mridha, Asit Ranjan and Madan, Karan and Malik, Prabhat Singh and Jain, Deepali},
  title = {Thoracic inflammatory myofibroblastic tumors: A decade-long retrospective study integrating clinicopathological and molecular features from a tertiary care centre},
  journal = {Virchows Archiv},
  year = {2026},
  volume = {489},
  number = {1},
  pages = {159--170},
  doi = {10.1007/s00428-026-04545-8}
}
Kostenlos starten →